HAOHAI BIOTEC (06826) announced the results of its second phase A-share repurchase program. As of August 14, 2025, the company has completed the current repurchase phase. Through the Shanghai Stock Exchange's centralized bidding trading system, the company has cumulatively repurchased 1.8324 million A-shares, representing 0.79% of the company's total share capital. The highest transaction price during the repurchase was 63.58 yuan per share, while the lowest price was 49.25 yuan per share, with an average repurchase price of 56.70 yuan per share. The total amount paid reached 103.9 million yuan (excluding stamp duty, transaction commissions and other fees).